BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1434 related articles for article (PubMed ID: 18725838)

  • 1. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Market and beneficiary characteristics associated with enrollment in Medicare managed care plans and fee-for-service.
    Shimada SL; Zaslavsky AM; Zaborski LB; O'Malley AJ; Heller A; Cleary PD
    Med Care; 2009 May; 47(5):517-23. PubMed ID: 19365291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of preventive services by Medicare fee-for-service beneficiaries: does spillover from managed care matter?
    Koroukian SM; Litaker D; Dor A; Cooper GS
    Med Care; 2005 May; 43(5):445-52. PubMed ID: 15838408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
    O'Malley AS; Forrest CB; Feng S; Mandelblatt J
    Arch Intern Med; 2005 Oct; 165(18):2129-35. PubMed ID: 16217003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service.
    Schenck AP; Klabunde CN; Warren JL; Peacock S; Davis WW; Hawley ST; Pignone M; Ransohoff DF
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):799-804. PubMed ID: 18381471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health plan policies and programs for colorectal cancer screening: a national profile.
    Klabunde CN; Riley GF; Mandelson MT; Frame PS; Brown ML
    Am J Manag Care; 2004 Apr; 10(4):273-9. PubMed ID: 15124504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in colorectal cancer test use in the medicare population, 1998-2005.
    Schenck AP; Peacock SC; Klabunde CN; Lapin P; Coan JF; Brown ML
    Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to colorectal cancer screening among Medicare consumers.
    Klabunde CN; Schenck AP; Davis WW
    Am J Prev Med; 2006 Apr; 30(4):313-9. PubMed ID: 16530618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dually eligible and colorectal cancer screening: too little, too late?
    Carcaise-Edinboro P; Bradley CJ; Dahman B
    J Health Care Poor Underserved; 2009 Aug; 20(3):854-65. PubMed ID: 19648712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
    Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E
    J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessments by sick and healthy beneficiaries in traditional Medicare and Medicare managed care.
    Keenan PS; Elliott MN; Cleary PD; Zaslavsky AM; Landon BE
    Med Care; 2009 Aug; 47(8):882-8. PubMed ID: 19543123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of performance of traditional Medicare vs Medicare managed care.
    Landon BE; Zaslavsky AM; Bernard SL; Cioffi MJ; Cleary PD
    JAMA; 2004 Apr; 291(14):1744-52. PubMed ID: 15082702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal occult blood test use by Kansas medicare beneficiaries.
    Engelman KK; Ellerbeck EF; Ahluwalia JS; Nazir N; Velasco A
    Prev Med; 2001 Dec; 33(6):622-6. PubMed ID: 11716659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic area variations in the Medicare health plan era.
    Keenan PS; Cleary PD; O'Malley AJ; Landon BE; Zaborski L; Zaslavsky AM
    Med Care; 2010 Mar; 48(3):260-6. PubMed ID: 20182269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.